# Rivaroxaban Acute Stroke Safety Study

> **NCT02279940** · — · COMPLETED · sponsor: **University of Alberta** · enrollment: 50 (actual)

## Conditions studied

- Acute Ischemic Stroke
- Transient Ischemic Attack

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02279940
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279940, "Rivaroxaban Acute Stroke Safety Study". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02279940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*